People and Business News – 4/23
The latest people and business news from the past month, all in one place.
People News
MMS Holdings announced the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors. Dr. Breitfeld is currently the chief medical officer for Allterum Therapeutics. Dr. Zeiher has also been the chief medical officer for Astellas Pharma for the past 12 years.
Catawba Research announced the hiring of Andy Silverman, PhD, as chief operating officer. Previously, Silverman worked as EVP, Global Operations for Syneos Health.
Greenphire announced the appointment of Steve Geffon to be its new chief commercial officer. Prior to joining Greenphire, Geffon spent three years in the same role at Science 37.
CluePoints revealed the hiring of Amit Patel as its new CFO. Patel joins CluePoints after serving in the same role at Siteimprove.
Innovative Trials appointed Eloise Moffett as its first commercial vice president. Before joining Innovative Trials, Moffet spent over two years as the senior director of business development for mdgroup.
EmVenio Research announced the appointment of Mark Mackenzie, MD, as chief medical officer. Previously, Mackenzie served as the vice president of clinical affairs at M-3 Wake Research.
COTA Inc. announced the hiring of Sandy Leonard as its chief commercial officer. Concurrently, Leonard is the founder of DAISE Consulting LLC.
TOTAL Diversity Clinical Management introduced three new executives to its staff including Gabrielle DeBoer as VP, business development; Jeremy Mitchell as director, business development; and Crystal Thigpen as marketing and communications director.
Recognition
Cluepoints has been shortlisted for the 2023 Citeline Awards in the Best Use of Artificial Intelligence in Clinical Trials category.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
